Literature DB >> 17923657

Is there a new role for angiotensin-converting-enzyme inhibitors in elderly patients?

Ann Cranney1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17923657      PMCID： PMC1995157          DOI： 10.1503/cmaj.071062

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Including older people in clinical research.

Authors:  Marion E T McMurdo; Miles D Witham; Neil D Gillespie
Journal:  BMJ       Date:  2005-11-05

Review 3.  Skeletal muscle apoptosis, sarcopenia and frailty at old age.

Authors:  Emanuele Marzetti; Christiaan Leeuwenburgh
Journal:  Exp Gerontol       Date:  2006-10-18       Impact factor: 4.032

Review 4.  Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance.

Authors:  Christy S Carter; Graziano Onder; Stephen B Kritchevsky; Marco Pahor
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-11       Impact factor: 6.053

Review 5.  Effect of creatine supplementation during resistance training on muscle accretion in the elderly.

Authors:  D G Candow; P D Chilibeck
Journal:  J Nutr Health Aging       Date:  2007 Mar-Apr       Impact factor: 4.075

6.  Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study).

Authors:  Marcello Maggio; Gian Paolo Ceda; Fulvio Lauretani; Marco Pahor; Stefania Bandinelli; Samer S Najjar; Shari M Ling; Shehzad Basaria; Carmelinda Ruggiero; Giorgio Valenti; Luigi Ferrucci
Journal:  Am J Cardiol       Date:  2006-03-31       Impact factor: 2.778

Review 7.  Sarcopenia: age-related skeletal muscle changes from determinants to physical disability.

Authors:  A Di Iorio; M Abate; D Di Renzo; A Russolillo; C Battaglini; P Ripari; R Saggini; R Paganelli; G Abate
Journal:  Int J Immunopathol Pharmacol       Date:  2006 Oct-Dec       Impact factor: 3.219

Review 8.  Sarcopenia--a potential target for Angiotensin-converting enzyme inhibition?

Authors:  Deepa Sumukadas; Allan D Struthers; Marion E T McMurdo
Journal:  Gerontology       Date:  2006       Impact factor: 5.140

9.  Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial.

Authors:  Deepa Sumukadas; Miles D Witham; Allan D Struthers; Marion E T McMurdo
Journal:  CMAJ       Date:  2007-10-09       Impact factor: 8.262

10.  Resistance exercise reverses aging in human skeletal muscle.

Authors:  Simon Melov; Mark A Tarnopolsky; Kenneth Beckman; Krysta Felkey; Alan Hubbard
Journal:  PLoS One       Date:  2007-05-23       Impact factor: 3.240
View more
  8 in total

Review 1.  Successful aging: Advancing the science of physical independence in older adults.

Authors:  Stephen D Anton; Adam J Woods; Tetso Ashizawa; Diana Barb; Thomas W Buford; Christy S Carter; David J Clark; Ronald A Cohen; Duane B Corbett; Yenisel Cruz-Almeida; Vonetta Dotson; Natalie Ebner; Philip A Efron; Roger B Fillingim; Thomas C Foster; David M Gundermann; Anna-Maria Joseph; Christy Karabetian; Christiaan Leeuwenburgh; Todd M Manini; Michael Marsiske; Robert T Mankowski; Heather L Mutchie; Michael G Perri; Sanjay Ranka; Parisa Rashidi; Bhanuprasad Sandesara; Philip J Scarpace; Kimberly T Sibille; Laurence M Solberg; Shinichi Someya; Connie Uphold; Stephanie Wohlgemuth; Samuel Shangwu Wu; Marco Pahor
Journal:  Ageing Res Rev       Date:  2015-10-14       Impact factor: 10.895

2.  Angiotensin-Converting Enzyme Inhibitor Use and Incident Frailty: A Longitudinal Cohort Study.

Authors:  Nicola Veronese; Brendon Stubbs; Lee Smith; Stefania Maggi; Sarah E Jackson; Pinar Soysal; Jacopo Demurtas; Stefano Celotto; Ai Koyanagi
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

3.  Multi-modal intervention to reduce cardiovascular risk among hypertensive older adults: Design of a randomized clinical trial.

Authors:  Thomas W Buford; Stephen D Anton; Anthony A Bavry; Christy S Carter; Michael J Daniels; Marco Pahor
Journal:  Contemp Clin Trials       Date:  2015-06-23       Impact factor: 2.226

4.  ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.

Authors:  Matteo Cesari; Claudio Pedone; Raffaele Antonelli Incalzi; Marco Pahor
Journal:  J Am Med Dir Assoc       Date:  2009-11-25       Impact factor: 4.669

Review 5.  Optimizing the benefits of exercise on physical function in older adults.

Authors:  Thomas W Buford; Stephen D Anton; David J Clark; Torrance J Higgins; Matthew B Cooke
Journal:  PM R       Date:  2013-12-19       Impact factor: 2.298

6.  Multimodal Intervention to Improve Functional Status in Hypertensive Older Adults: A Pilot Randomized Controlled Trial.

Authors:  Liliana C Baptista; Byron C Jaeger; Stephen D Anton; Anthony A Bavry; Eileen M Handberg; Anna K Gardner; Sara A Harper; Lisa M Roberts; Bhanuprasad Sandesara; Christy S Carter; Thomas W Buford
Journal:  J Clin Med       Date:  2019-02-06       Impact factor: 4.241

7.  Angiotensin Converting Enzyme Inhibitors Combined with Exercise for Hypertensive Seniors (The ACES Trial): Study Protocol of a Randomized Controlled Trial.

Authors:  Sara A Harper; Liliana C Baptista; Lisa M Roberts; Sarah J Wherry; Rebecca S Boxer; Kerry L Hildreth; Regina S Seay; P Hunter Allman; Christy S Carter; Inmaculada Aban; Wendy M Kohrt; Thomas W Buford
Journal:  Front Med (Lausanne)       Date:  2020-01-22

8.  Protocol for a single-centre, randomised controlled study of a preoperative rehabilitation bundle in the frail and elderly undergoing abdominal surgery.

Authors:  Hairil Rizal Abdullah; Victoria Peixin Lien; Hwee Kuan Ong; Pei Ling Er; Ying Hao; Shariq Ali Khan; Christopher Weiyang Liu
Journal:  BMJ Open       Date:  2017-08-04       Impact factor: 2.692
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.